Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc
- PMID: 18541720
- DOI: 10.1182/blood-2008-01-132035
Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc
Abstract
Leukocyte adhesion deficiency II (LAD II), also known as congenital disorder of glycosylation IIc (CDG-IIc), is a human disease in which a defective GDP-fucose transporter (SLC35C1) causes developmental defects and an immunodeficiency that is based on the lack of fucosylated selectin ligands. Since the study of in vivo leukocyte trafficking in patients with LAD II is experimentally limited, we analyzed this process in mice deficient for Slc35c1. We found that E-, L-, and P-selectin-dependent leukocyte rolling in cremaster muscle venules was virtually absent. This was accompanied by a strong but not complete decrease in firm leukocyte adhesion. Moreover, neutrophil migration to the inflamed peritoneum was strongly reduced by 89%. Previous reports showed surprisingly normal lymphocyte functions in LAD II, which indicated sufficient lymphocyte trafficking to secondary lymphoid organs. We now found that while lymphocyte homing to lymph nodes was reduced to 1% to 2% in Slc35c1(-/-) mice, trafficking to the spleen was completely normal. In accordance with this, we found a defect in the humoral response to a T cell-dependent antigen in lymph nodes but not in the spleen. Taken together, Slc35c1(-/-) mice show strongly defective leukocyte trafficking but normal lymphocyte homing to the spleen, which may explain normal lymphocyte functions in LAD II.
Similar articles
-
Golgi GDP-fucose transporter-deficient mice mimic congenital disorder of glycosylation IIc/leukocyte adhesion deficiency II.J Biol Chem. 2007 Apr 6;282(14):10762-72. doi: 10.1074/jbc.M700314200. Epub 2007 Feb 2. J Biol Chem. 2007. PMID: 17276979
-
Mutations in the SLC35C1 gene, contributing to significant differences in fucosylation patterns, may underlie the diverse phenotypic manifestations observed in leukocyte adhesion deficiency type II patients.Int J Biochem Cell Biol. 2024 Aug;173:106602. doi: 10.1016/j.biocel.2024.106602. Epub 2024 Jun 4. Int J Biochem Cell Biol. 2024. PMID: 38843991
-
Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.J Clin Invest. 1998 Jun 1;101(11):2438-45. doi: 10.1172/JCI905. J Clin Invest. 1998. PMID: 9616215 Free PMC article.
-
Defining the mild variant of leukocyte adhesion deficiency type II (SLC35C1-congenital disorder of glycosylation) and response to l-fucose therapy: Insights from two new families and review of the literature.Am J Med Genet A. 2022 Jul;188(7):2005-2018. doi: 10.1002/ajmg.a.62737. Epub 2022 Mar 26. Am J Med Genet A. 2022. PMID: 35338746 Review.
-
Leukocyte adhesion deficiency II-from A to almost Z.Immunol Rev. 2000 Dec;178:138-47. doi: 10.1034/j.1600-065x.2000.17805.x. Immunol Rev. 2000. PMID: 11213799 Review.
Cited by
-
Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands.Blood. 2012 Aug 2;120(5):1015-26. doi: 10.1182/blood-2012-04-424366. Epub 2012 Jun 13. Blood. 2012. PMID: 22700726 Free PMC article.
-
L-fucose, a sugary regulator of antitumor immunity and immunotherapies.Mol Carcinog. 2022 May;61(5):439-453. doi: 10.1002/mc.23394. Epub 2022 Feb 2. Mol Carcinog. 2022. PMID: 35107186 Free PMC article. Review.
-
Lessons from rare maladies: leukocyte adhesion deficiency syndromes.Curr Opin Hematol. 2013 Jan;20(1):16-25. doi: 10.1097/MOH.0b013e32835a0091. Curr Opin Hematol. 2013. PMID: 23207660 Free PMC article. Review.
-
Human deficiencies of fucosylation and sialylation affecting selectin ligands.Semin Immunopathol. 2012 May;34(3):383-99. doi: 10.1007/s00281-012-0304-1. Epub 2012 Mar 31. Semin Immunopathol. 2012. PMID: 22461019 Review.
-
T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Lab Invest. 2017 Jun;97(6):669-697. doi: 10.1038/labinvest.2017.25. Epub 2017 Mar 27. Lab Invest. 2017. PMID: 28346400 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases